We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
FCDO travel advice for Colombia. Includes safety and security, insurance, entry requirements and legal differences.
Your travel insurance could be invalidated if you travel against advice…
This information is for people travelling on a full ‘British citizen’…
Terrorism There is a high threat of terrorist attack globally affecting UK…
This section has safety advice for regions of Colombia. It only covers…
Before you travel check that: your destination can provide the healthcare…
The Foreign, Commonwealth & Development Office (FCDO) cannot provide…
The UK suspension of the MAGEC system (modified MAGEC X system only) has been lifted as of 23 February 2024
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages. The article also includes information on a recent National Patient Safety Alert...
Latest FCDO travel advice for Mexico including on entry requirements, safety and security and local laws and customs.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (27 December) approved the advanced melanoma medicine Opdualag (nivolumab-relatlimab) for patients from the age of 12.
Closed: Call for proposals by 9 February 2024 for the design and construction of a pilot investment index to mobilise private capital through listed investment products.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
To better understand Mpox and its spread within the UK, VDEC developed an immunoassay to assess immune responses to Mpox infection and new vaccines.
Closed: Call for proposals by 2 February 2024 to provide analysis of development finance investments and strategies, including their influence on similar financial transactions and impact on global financial markets.
The MHRA has conducted a thorough assessment of technical and biological safety information provided by NSO and is satisfied that the modified MAGEC X system can now be used in the UK.
Research on capital allocation strategy for emerging/frontier markets, and the role of information asymmetry in shaping capital flows.
Closed: call for proposals by 13 December 2023 for consultancy support on a policy review for allocating proceeds in an infrastructure debt securitisation platform, and recommendations for verifying allocations to MOBILIST investments.
The study shows partial antiviral activity of maraviroc (MVC) when tested in multiple preclinical dosing strategies
There is a single point of contact (SPOC) for former and serving personnel concerned about their experience of Mefloquine (also known as Lariam) which launches 5 September 2016.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).